BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15223002)

  • 21. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone response to low-dose apomorphine in restless legs syndrome.
    Happe S; Bachmann CG; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Growth Horm IGF Res; 2007 Aug; 17(4):323-7. PubMed ID: 17512770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
    Frauscher B; Gschliesser V; Brandauer E; El-Demerdash E; Kaneider M; Rücker L; Poewe W; Högl B
    Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Restless legs syndrome].
    Lai SC; Chen RS
    Acta Neurol Taiwan; 2008 Mar; 17(1):54-65. PubMed ID: 18564830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient restless legs-like syndrome as a complication of opiate withrawal.
    Scherbaum N; Stüper B; Bonnet U; Gastpar M
    Pharmacopsychiatry; 2003; 36(2):70-2. PubMed ID: 12734764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.
    Clemens S; Rye D; Hochman S
    Neurology; 2006 Jul; 67(1):125-30. PubMed ID: 16832090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of salivary melatonin measurements for Dim Light Melatonin Onset calculations in patients with possible sleep-wake rhythm disorders.
    Keijzer H; Smits MG; Peeters T; Looman CW; Endenburg SC; Gunnewiek JM
    Clin Chim Acta; 2011 Aug; 412(17-18):1616-20. PubMed ID: 21601566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restless legs syndrome in 2004.
    Sonka K; Kemlink D
    Prague Med Rep; 2004; 105(4):337-56. PubMed ID: 15822631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).
    Benes H; Kohnen R
    Sleep Med; 2009 May; 10(5):515-23. PubMed ID: 18823819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary and plasma measures of dim light melatonin onset (DLMO) in patients with rapid cycling bipolar disorder.
    Leibenluft E; Feldman-Naim S; Turner EH; Schwartz PJ; Wehr TA
    Biol Psychiatry; 1996 Oct; 40(8):731-5. PubMed ID: 8894065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice].
    Mühlau G
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin concentration as a marker of the circadian phase in patients with obstructive sleep apnoea.
    Papaioannou I; Twigg GL; Kemp M; Roughton M; Hooper J; Morrell MJ; Polkey MI
    Sleep Med; 2012 Feb; 13(2):167-71. PubMed ID: 22206710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome.
    Vetrugno R; Contin M; Baruzzi A; Provini F; Plazzi G; Montagna P
    Mov Disord; 2006 Feb; 21(2):254-8. PubMed ID: 16200540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization.
    Hening W
    Clin Neurophysiol; 2004 Sep; 115(9):1965-74. PubMed ID: 15294199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of simulated hypo- and hyper-reproductive conditions on the characteristics of circadian rhythm in hypothalamic concentration of serotonin and dopamine and in plasma levels of thyroxine, triiodothyronine, and testosterone in Japanese quail, Coturnix coturnix japonica.
    Kumar P; Pati AK; Mohan J; Sastry KV; Tyagi JS; Chaturvedi CM
    Chronobiol Int; 2009 Jan; 26(1):28-46. PubMed ID: 19142756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients.
    Enomoto M; Inoue Y; Namba K; Munezawa T; Matsuura M
    Mov Disord; 2008 Apr; 23(6):811-6; quiz 926. PubMed ID: 18074382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas.
    Delgado Rodrigues RN; Alvim de Abreu E Silva Rodrigues AA; Pratesi R; Krieger J
    Sleep Med; 2006 Apr; 7(3):235-9. PubMed ID: 16564217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Restless legs syndrome: therapeutic possibilities in the medical practice].
    Bachmann CG; Trenkwalder C
    MMW Fortschr Med; 2005 May; 147 Spec No 2():44-7. PubMed ID: 15968872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.